Chi Liu

1.1k total citations
39 papers, 834 citations indexed

About

Chi Liu is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chi Liu has authored 39 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Nephrology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chi Liu's work include Parathyroid Disorders and Treatments (6 papers), Renal and related cancers (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Chi Liu is often cited by papers focused on Parathyroid Disorders and Treatments (6 papers), Renal and related cancers (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Chi Liu collaborates with scholars based in China, United States and Japan. Chi Liu's co-authors include Jinghong Zhao, Jiachuan Xiong, Xianjin Bi, Jing Gao, Qifen Yang, Ke Yang, Deqin Yang, Li Li, Lingfei Luo and Wenhao Han and has published in prestigious journals such as Nature Communications, Immunity and The FASEB Journal.

In The Last Decade

Chi Liu

37 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi Liu China 15 411 163 162 100 80 39 834
Gábor Kökény Hungary 18 435 1.1× 100 0.6× 222 1.4× 106 1.1× 121 1.5× 36 1.0k
Jeong Suk Kang South Korea 17 350 0.9× 112 0.7× 251 1.5× 40 0.4× 55 0.7× 24 843
Changhong Du China 18 444 1.1× 206 1.3× 107 0.7× 87 0.9× 105 1.3× 38 1.0k
Mutsuyoshi Matsushita Japan 19 348 0.8× 224 1.4× 73 0.5× 99 1.0× 44 0.6× 47 1.2k
H. Wu China 15 337 0.8× 113 0.7× 230 1.4× 56 0.6× 75 0.9× 24 820
Eirini Kefaloyianni United States 15 500 1.2× 200 1.2× 126 0.8× 74 0.7× 68 0.8× 23 1.1k
Congwei Luo China 16 529 1.3× 126 0.8× 272 1.7× 211 2.1× 99 1.2× 22 1.0k

Countries citing papers authored by Chi Liu

Since Specialization
Citations

This map shows the geographic impact of Chi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Liu more than expected).

Fields of papers citing papers by Chi Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Liu. The network helps show where Chi Liu may publish in the future.

Co-authorship network of co-authors of Chi Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Chi Liu. A scholar is included among the top collaborators of Chi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Liu. Chi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Bin, Rui Ma, Yuqiang Wu, Chi Liu, & Xiangrong Song. (2025). Immune mechanisms in chronic kidney disease-mineral and bone disorder: current insights and therapeutic implications. Frontiers in Medicine. 12. 1678640–1678640.
2.
Yang, Wenmin, et al.. (2024). odd skipped-related 2 as a novel mark for labeling the proximal convoluted tubule within the zebrafish kidney. Heliyon. 10(6). e27582–e27582. 1 indexed citations
3.
Tang, Xudong, et al.. (2024). Ferroptosis: a new mechanism of traditional Chinese medicine for treating hematologic malignancies. Frontiers in Oncology. 14. 1469178–1469178. 3 indexed citations
4.
Liu, Chi, Xiaoqin Tan, Wenmin Yang, et al.. (2023). Proenkephalin-A secreted by renal proximal tubules functions as a brake in kidney regeneration. Nature Communications. 14(1). 7167–7167. 5 indexed citations
5.
Fang, Peng, Zhongyu Han, Hao Chen, et al.. (2023). The Effects of Treatment with Icariin on Immune Tolerance in the Recurrent Spontaneous Abortion Mice. Reproductive Sciences. 30(9). 2794–2804. 6 indexed citations
6.
Wang, Wei, et al.. (2023). Research Progress of Pyroptosis in Renal Diseases. Current Medicinal Chemistry. 31(40). 6656–6671. 7 indexed citations
7.
Yu, Ting, Xiaoqin Tan, Da‐Qing Jin, et al.. (2023). Renal interstitial cells promote nephron regeneration by secreting prostaglandin E2. eLife. 12. 12 indexed citations
8.
Liu, Chi, Yin Chen, Shu‐Yi Liao, et al.. (2023). Cobaltosic oxide-polyethylene glycol-triphenylphosphine nanoparticles ameliorate the acute-to-chronic kidney disease transition by inducing BNIP3-mediated mitophagy. Kidney International. 103(5). 903–916. 23 indexed citations
9.
Liu, Chi, et al.. (2022). N6-Methyladenosine RNA Methylation in Cardiovascular Diseases. Frontiers in Cardiovascular Medicine. 9. 887838–887838. 34 indexed citations
10.
Yang, Wenmin, et al.. (2021). Establishment of a Drug Screening Model for Cardiac Complications of Acute Renal Failure. Biomolecules. 11(9). 1370–1370. 6 indexed citations
12.
Liu, Chi, et al.. (2021). A narrative review of circular RNAs as potential biomarkers and therapeutic targets for cardiovascular diseases. Annals of Translational Medicine. 9(7). 578–578. 14 indexed citations
13.
Li, Yunlong, et al.. (2021). Immunomodulatory Effects of Heme Oxygenase-1 in Kidney Disease. Frontiers in Medicine. 8. 708453–708453. 17 indexed citations
14.
Yu, Ting, Fang Zhang, Jianli Chen, et al.. (2020). Detailed process analysis for glomerular capillary formation by immunofluorescence on ultra-thick sections. Gene Expression Patterns. 35. 119096–119096. 2 indexed citations
15.
Li, Yan, Yong Liu, Kailong Wang, et al.. (2020). Klotho is regulated by transcription factor Sp1 in renal tubular epithelial cells. BMC Molecular and Cell Biology. 21(1). 45–45. 15 indexed citations
16.
Huang, Yinghui, Shaobo Wang, Jie Zhou, et al.. (2020). IRF1-mediated downregulation of PGC1α contributes to cardiorenal syndrome type 4. Nature Communications. 11(1). 4664–4664. 49 indexed citations
17.
He, Ting, Jiachuan Xiong, Yinghui Huang, et al.. (2019). Klotho restrain RIG-1/NF-κB signaling activation and monocyte inflammatory factor release under uremic condition. Life Sciences. 231. 116570–116570. 19 indexed citations
18.
Liu, Yong, Xianjin Bi, Jiachuan Xiong, et al.. (2019). MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells. Molecular Therapy. 27(5). 1051–1065. 127 indexed citations
19.
Luo, Ming, Yi Shen, Chi Liu, et al.. (2011). Long-Term Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitory Peptide LAP. Kidney & Blood Pressure Research. 34(5). 358–364. 4 indexed citations
20.
Xia, Min, Wenhua Ling, Jing Ma, et al.. (2008). Anthocyanin attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation. Atherosclerosis. 202(1). 41–47. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026